Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer
Clinical trial NCT05462613 · RECRUITING
Trial details
- NCT number
- NCT05462613
- Sponsor
- Centre Hospitalier Universitaire de Besancon
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-09
- Primary completion
- 2029-11-01
- Enrollment
- 446
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.